Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 15/20 | 0.73 |
| ▸ | NFE2L2 | Q16236 | 10/20 | 0.73 |
| ▸ | SQSTM1 | Q13501 | 3/20 | 0.73 |
| ▸ | MITF | O75030 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | CASP1 | P29466 | 1/20 | 0.64 |
| ▸ | GFER | P55789 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.62 |
| ▸ | STAT3 | P40763 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26089402 | 0.85 | KEAP1 (1.00) | KEAP1NFE2L2SQSTM1MITFALDH1A1 | |
| SCHEMBL30083697 | 0.81 | SLC16A3 (0.76) | KEAP1NFE2L2SQSTM1ALDH1A1LMNA | |
| SCHEMBL28374542 | 0.81 | SLC16A3 (0.76) | KEAP1NFE2L2SQSTM1ALDH1A1LMNA | |
| SCHEMBL3798634 | 0.80 | APP (0.55) | L3MBTL1SLC16A3 | |
| SCHEMBL29028543 | 0.79 | KEAP1 (0.86) | KEAP1NFE2L2SQSTM1MITFALDH1A1 | |
| SCHEMBL23443367 | 0.78 | KEAP1 (1.00) | KEAP1NFE2L2SQSTM1MITFALDH1A1 | |
| SCHEMBL29892350 | 0.78 | KEAP1 (0.83) | KEAP1NFE2L2SQSTM1MITFALDH1A1 | |
| SCHEMBL28347367 | 0.78 | KEAP1 (0.83) | KEAP1NFE2L2SQSTM1MITFALDH1A1 | |
| SCHEMBL21511039 | 0.78 | GAA (1.00) | KEAP1NFE2L2SQSTM1MITFALDH1A1 | |
| SCHEMBL28347360 | 0.78 | STAT3 (0.77) | KEAP1NFE2L2SQSTM1MITFALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11396496-B2 | 1,4-substituted isoquinoline inhibitors of KEAP1/NRF2 protein-protein interaction | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-07-26 | — | — | US | disclosed |
| EP-3773536-A1 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | The Board of Trustees of the University of Illinois (US) | 2021-02-17 | — | — | EP | disclosed |
| CN-112367983-A | 1,4 substituted isoquinoline inhibitors of KEAP1/NRF2 protein-protein interaction | 伊利诺伊大学评议会 | 2021-02-12 | — | — | CN | disclosed |
| US-20210017135-A1 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2021-01-21 | — | — | US | disclosed |
| US-20210017135-A1 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2021-01-21 | — | — | US | disclosed |
| WO-2019195348-A1 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-10-10 | — | — | WO | disclosed |
| WO-2019195348-A1 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2019-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11396496-B2 | 1,4-substituted isoquinoline inhibitors of KEAP1/NRF2 protein-protein interaction | KEAP1, NFE2L2, NFE2 | KEAP1 1/4885NFE2L2 2/4885SQSTM1 347/4885 |
| US-20210017135-A1 | 1,4-SUBSTITUTED ISOQUINOLINE INHIBITORS OF KEAP1/NRF2 PROTEIN-PROTEIN INTERACTION | KEAP1, NFE2L2, NFE2 | KEAP1 1/4885NFE2L2 2/4885SQSTM1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.